Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 1
Sponsor overview
Flame Biosciences
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT05181865
Assets
Linked programs
- 1 mg/kg IV FL-301: Registry Stop Signal (4/5)